Allergan Transfers Restasis Patents To IPR-Immune Tribe
Allergan PLC has transferred the patents for its dry eye treatment Restasis to a Native American tribe with sovereign immunity in a bid to escape inter partes review proceedings before the...To view the full article, register now.
Already a subscriber? Click here to view full article